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Abstract
Background: Data from several previous studies examining heart-rate and cardiovascular risk have hinted at a possible
relationship between heart-rate and non-cardiac mortality. We thus systematically examined the predictive value of heart-
rate variables on the subsequent risk of death from cancer.
Methods: In the Paris Prospective Study I, 6101 asymptomatic French working men aged 42 to 53 years, free of clinically
detectable cardiovascular disease and cancer, underwent a standardized graded exercise test between 1967 and 1972.
Resting heart-rate, heart-rate increase during exercise, and decrease during recovery were measured. Change in resting
heart-rate over 5 years was also available in 5139 men. Mortality including 758 cancer deaths was assessed over the 25 years
of follow-up.
Findings: There were strong, graded and significant relationships between all heart-rate parameters and subsequent cancer
deaths. After adjustment for age and tobacco consumption and, compared with the lowest quartile, those with the highest
quartile for resting heart-rate had a relative risk of 2.4 for cancer deaths (95% confidence interval: 1.9–2.9, p,0.0001) This
was similar after adjustment for traditional cardiovascular risk factors and was observed for the commonest malignancies
(respiratory and gastrointestinal). Similarly, significant relationships with cancer death were observed between poor heart
rate increase during exercise, poor decrease during recovery and greater heart-rate increase over time (p,0.0001 for all).
Interpretation: Resting and exercise heart rate had consistent, graded and highly significant associations with subsequent
cancer mortality in men.
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Introduction
Heart-rate plays a central role in the cardiovascular system and
depends on the balance between vagal and adrenergic tone. Higher
levels of resting heart-rate have been associated with total and
especially cardiovascular mortality in numerous studies [1–22]. The
pattern of heart-rate increase during exercise and decrease during
recovery has also been associated with all-cause mortality by several
authors, [6–8,11,16] with cardiovascular mortality [11,15,16] and
sudden cardiac death[11] by others. Some studies involved
cardiovascular patients usually referred for an exercise test, [6–
8,15,16] whereas others involved the general population [11].
Interestingly, several of these studies have shown little if any
difference between the relative risk for cardiovascular death compared
with total mortality, associated with higher resting heart rate [23]. For
example, an association between resting heart-rate and non
cardiovascular mortality (relative risk=1.16, confidence inter-
val=1.13–1.19) was noted in 379,843 middle-aged men and women
from Norway, similar to the 1.10 (CI:1.05–1.15) for cardiovascular and
1.14 (CI:1.11–1.17) for total death, but as stated by the authors: ‘‘since
it was not the focus of the study, this finding was not pursued’’ [22].
Such data suggest the possibility that higher resting heart rate may be
equally associated with non cardiovascular death,the majorityof which
would be expected to be due to cancer in developed countries. Few
data are available however to examine the relationships between heart-
rate variables and cancer mortality. Although an association between a
high level of heart-rate and cancer mortality was hypothesized 30 years
ago in two of three epidemiologic studies from Chicago[24], this
possible association has not been comprehensively examined.
Thepurposeofthepresentworkwasthustoexaminespecificallyand
prospectively the potential associations between different heart-rate
parameters and various causes of cancer mortality, in a well
characterized general population. The Paris Prospective Study I gave
usauniqueopportunitytoaddresstheseissuesas notonlyrestingheart-
rate but also the heart-rate pattern during exercise, recovery and the
heart-rate change over 5 years were measured in the same study, and
different causes of mortality were followed up over more than 25 years.
Methods
Details of the Paris Prospective Study 1 concerning the
recruitment, design, and procedures have been described
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native Frenchmen employed by the Paris Civil Service, aged 42 to
53 years, was carried out from 1967 to 1972. That sample
consisted of 93.4 percent of the total number of employees in early
1967 who were born between 1917–1928. Subjects had electro-
cardiograms and physical examinations conducted by a physician,
provided blood samples for laboratory tests, and answered
questionnaires administered by trained interviewers. Resting
heart-rate was clinically determined by measurement of the radial
pulse during a one-minute recording, after five-minutes rest in the
supine position. Diabetic status was defined as past or present
reported diabetes, whether treated or not. Tobacco consumption
was assessed by questionnaires and reported as the average use in
grams per day over the 5 years preceding the study. Current
physical activity applied to subjects who performed more than one
hour of regular activity per week.
Exercise test protocol
The standardized protocol of the bicycle exercise test performed
has been described previously [11]. It consisted of 3 successive
work loads: 2 min at 82 W, 6 min at 164 W and the last 2 min at
191 W for a maximal 10-min test duration. There was no cool-
down period. Cardiac rhythm was continuously monitored, and a
bipolar lead (V5 and V5R) was recorded at rest and for 30 sec
every 2 min during exercise, at maximal effort and every 1 min
during the 10-min recovery time, or whenever the monitoring
physician observed an arrhythmia. Heart-rate was measured at
rest, before exercise, every two minutes during exercise, at peak
exercise and every minute during recovery. Testing was
terminated because of fatigue, dyspnea, leg discomfort, any chest
pain, systolic blood pressure.250 mm Hg, heart-rate $ 180
beats/min, ventricular tachycardia or ischemic electrocardio-
graphic changes. Exercise testing was carried out in 6565 men,
with complete data available for 6456.
Heart-rate measurements
In addition to resting heart-rate, three other heart-rate
parameters were defined as being of potential significance.
Firstly, the heart-rate increase during exercise was the difference
between the maximum heart-rate achieved at peak exercise and
resting heart-rate [11]. Secondly, the heart-rate during recovery
was the difference between maximum heart-rate achieved at
maximum exercise and heart-rate recorded one minute later [11].
Thirdly, heart-rate change after 5 years was the difference
between resting heart-rate recorded at baseline and 5 years later,
available in the 5139 men who completed the 5 year follow-up
examination [12].
Follow-up
Until retirement (official age 65 years), the administrative
department in charge of the study population provided a list of
deceased subjects annually. All available data relevant to the
causes of death were collected from specific inquiries, i.e. medical
records from hospital departments or general practitioners
indicated by the relatives of the deceased. The data were then
reviewed by an independent medical committee. After retirement
(usually after age 65), causes of death were obtained from death
certificates. The eighth and ninth revisions of the International
Classification of Diseases [26] were used for coding. The end of
the follow-up period was January 1, 1994. Vital status could not be
determined for 355 subjects (4.6 percent). Their characteristics at
baseline and during exercise were not significantly different from
the remaining 6101 men studied.
Statistical methods
All statistical analyses were performed using SAS 9.1.3 (Cary,
Nc). Hazards ratios (HRs) of each heart rate parameter for each
study outcome were estimated in separate Cox proportional
hazard models. Multivariate-adjusted HRs on known cancer risk
factors (age and tobacco consumption) were quantified. For the
purpose of comparison, mortality risks were assessed in a second
model for traditional cardiovascular risk factors (age, body mass
index, systolic blood pressure, diabetes mellitus, tobacco con-
sumption, current physical activity and blood level of cholesterol).
In all analyses, each heart-rate parameter was divided in quartiles
and the first quartile (the lowest value) was taken as the reference
category.
The results of the survival analyses were also represented
graphically using Cox multivariate survival model of proportional
hazard assumption. In each graph, we plotted the predicted
survival curves for each of the quartiles of heart-rate.
When the evolution of heart-rate after 5 years was entered into
the model, the statistical analysis was restricted to the 5,139
subjects for whom that variable was available. Additional
sensitivity analyses were carried out (i) excluding causes of death
assessed from death certificates only, (ii) after exclusion of the 48
cancer deaths which occurred in the first 5 years after baseline
study, to exclude the possibility that resting or exercise related
heart-rate might have been related to undiagnosed malignancy at
the time of baseline visit, and (iii) after splitting smoking-related
and other cancers.
Results
Among the 6101 men, and after 25 years of follow-up
representing over 150 000 person years of observation, 1635
deaths were recorded, with 435 cardiovascular deaths and 1200
non cardiovascular deaths. These included 771 deaths due to
cancer, with 241 deaths of pulmonary origin, (including 178 of
trachea, bronchus and lung and 43 of larynx) 210 of gastrointes-
tinal origin (including 67 of colon and rectum, 42 of oesophagus,
27 of stomach, 32 of liver, and 32 of pancreas), 89 of genitourinary
origin (including 44 of prostate and 25 of bladder) and 231
miscellaneous (including 108 of unspecified sites, 53 of lymphatic
and hematopoietic tissue, and 9 of unspecified nature). The
baseline characteristics of subjects by mortality causes are shown in
table 1. Those who died from cancer had the highest level of
tobacco consumption whereas those who died from cardiovascular
causes had the highest body mass index, systolic blood pressure,
cholesterol level and the highest proportion of diabetes mellitus.
Subjects were divided into quartiles according to the level of
resting heart-rate (interquartile values in beats per min: 60, 67 and
73); of heart-rate increase during exercise (interquartile values in
beats per min: 85, 99 and 109); of heart rate decrease after one
minute recovery (interquartile values in beats per min: 25, 32 and
39); and of heart-rate change after 5 years (interquartile values in
beats per min: 28, 21, and +5).
The age and tobacco-adjusted hazard ratios of mortality for the
highest quartiles of each heart-rate parameter are reported in
table 2. As expected, the heart-rate pattern at rest, during exercise
and recovery had a graded and significant association with total
and cardiovascular mortality.
A graded and increased risk for noncardiovascular and cancer
mortality was observed with (i) a higher resting heart-rate, (ii) a
poorer heart-rate increase during exercise and (iii) a slower
decrease of heart-rate during recovery, although the relationship
did not always reach statistical significance for the last. For
example, the relative risk of cancer death for subjects in the highest
Heart Rate and Risk of Cancer Death in Healthy Men
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(1.9–2.9, p,0.001). Higher heart-rate increase after 5 years was
also predictive of subsequent cancer mortality. Analysis by cancer
causes (gastrointestinal and respiratory) yielded similar trends as
for death from overall cancer, although statistical significance was
generally not reached.
A series of survival curves by quartile of heart rate parameters
are plotted in figures 1, 2 and 3 after adjustment for age, body
Table 1. Baseline characteristics of the 6101 men according to causes of mortality.
Mortality
All-cause
mortality
Cardio
vascular
mortality
Non
cardiovascular
mortality Cancer mortality Alive
all respiratory digestive
genito-
urinary
other or
unknown
(n=1635) (n=435) (n=1200) (n=771) (n=241) (n=210) (n=89) (n=231) (n=4466)
Age (y) 48.0 (1.8) 48.0 (1.8) 48.0 (1.8) 48.0 (1.8) 47.9 (1.9) 48.1 (1.8) 48.3 (1.7) 47.8 (1.7) 47.5 (2.0)
Body-mass index (kg/m
2) 25.7 (3.5) 26.1 (3.3) 25.5 (3.7) 25.4 (3.6) 24.7 (3.4) 26.1 (3.7) 26.0 (3.4) 25.3 (3.6) 25.8 (3.0)
Systolic blood pressure
(mmHg)
14.9 (2.1) 15.0 (2.1) 14.8 (2.1) 14.7 (2.0) 14.6 (2.1) 14.9 (2.0) 14.7 (2.0) 14.8 (2.1) 14.1 (2.0)
Total cholesterol (mg/dl) 223 (45) 235 (47) 219 (44) 218 (42) 217 (42) 221 (44) 219 (40) 217 (41) 222 (41)
Tobacco consumption
(g/day)
15.2 (10.7) 14.1 (10.1) 15.6 (10.8) 16.8 (10.6) 20.6 (9.5) 14.5 (11.2) 13.4 (9.1) 16.4 (10.8) 10.5 (10.2)
Leukocytes (610
9 units/l) 6.8 (2.0) 6.8 (1.9) 6.7 (2.1) 6.9 (2.1) 7.2 (2.0) 6.6 (1.9) 6.4 (1.8) 7.0 (2.4) 6.3 (1.8)
Hemoglobin (g/l) 15.1 (1.0) 15.1 (1.0) 15.1 (1.0) 15.1 (1.0) 15.1 (1.1) 15.1 (1.0) 15.2 (0.9) 15.1 (1.0) 15.1 (0.9)
Current physical activity 10.7% 13.4% 9.7% 10.3% 10.1% 9.2% 10.5% 11.2% 16.5%
Diabetes mellitus 1.5% 1.6% 1.5% 1.3% 0.8% 1.9% 0% 1.8% 1.0%
Continuous data are given as mean (standard deviation)
Tobacco consumption is the average consumption (grams per day) in the five years preceding the study.
Physical activity applies to subjects who performed more than one hour of regular activity per week.
The Paris Prospective Study I.
doi:10.1371/journal.pone.0021310.t001
Table 2. Age and tobacco adjusted relative risks of death according to quartiles of heart-rate parameters.
Mortality Relative Risk (95% CI)
quartile
All-cause mortality
(n=1635)
Cardio vascular
mortality (n=435)
Non cardio vascular
mortality (n=1200)
All-cause cancer
mortality (n=771)
Respiratory cancer
mortality (n=241)
Digestive cancer
mortality (n=210)
Resting HR 2
nd 1.3 [1.2;1.6] 1.4 [1.0;1.8] 1.3 [1.1;1.6] 1.6 [1.2;2.0] 1.8 [1.2;2.7] 1.6 [1.0;2.5]
3
rd 1.5 [1.3;1.8] *** 1.6 [1.2;2.1] *** 1.5 [1.3;1.8] *** 1.6 [1.3;2.0] *** 1.5 [1.0;2.3] *** 1.6 [1.1;2.5] ***
4
th 2.1 [1.8;2.4] 2.0 [1.5;2.7] 2.1 [1.8;2.5] 2.4 [1.9;2.9] 3.0 [2.1;4.5] 2.3 [1.5;3.3]
DHRexercise 2
nd 1.3 [1.1;1.5] 1.8 [1.3;2.3] 1.1 [1.0;1.4] 1.1 [0.9;1.4] 0.9 [0.6;1.4] 1.1 [0.7;1.6]
3
rd 1.6 [1.4;1.8] *** 2.1 [1.6;2.8] *** 1.4 [1.2;1.7] *** 1.4 [1.1;1.7] *** 1.5 [1.0;2.2] *** 1.1 [0.8;1.7]
4
th 1.7 [1.5;2.0] 2.3 [1.8;3.0] 1.6 [1.4;1.9] 1.6 [1.3;1.9] 2.0 [1.4;2.9] 1.4 [0.9;2.0]
DHRrecovery 2
nd 1.1 [1.0;1.3] 1.0 [0.7;1.3] 1.2 [1.0;1.4] 1.1 [0.9;1.4] 1.3 [0.8;1.9] 1.2 [0.8;1.8]
3
rd 1.0 [0.9;1.2] *** 0.9 [0.7;1.2] 1.1 [0.9;1.3] *** 1.0 [0.8;1.3] *** 1.1 [0.7;1.6] ** 1.0 [0.7;1.6]
4
th 1.4 [1.3;1.6] 1.3 [1.0;1.6] 1.5 [1.3;1.8] 1.5 [1.2;1.8] 1.8 [1.3;2.5] 1.4 [1.0;2.0]
DHR5year
1 2
nd 1.1 [0.9;1.4] 0.8 [0.5;1.2] 1.2 [1.0;1.6] 1.4 [1.0;1.8] 1.5 [0.9;2.4] 1.3 [0.8;2.2]
3
rd 1.2 [1.0;1.4] *** 1.1 [0.7;1.5] 1.2 [1.0;1.5] *** 1.1 [0.9;1.5] ** 1.1 [0.7;1.9] 1.2 [0.7;2.0]
4
th 1.7 [1.4;2.0] 1.2 [0.9;1.8] 1.9 [1.5;2.3] 1.6 [1.2;2.2] 1.7 [1.0;2.9] 1.4 [0.8;2.4]
DHRexercise: difference between heart-rate at peak exercise and resting heart-rate
DHRrecovery: difference between heart-rate at peak exercise and after 1 min recovery
DHR5year: difference between resting heart-rate recorded at year 5 and at baseline
1The analysis is restricted to 5139 subjects, see methods
Relative risk that was associated with a heart-rate measurement is given for the second, third and fourth quartile, taken the first quartile as reference. Relative risks were
estimated with the Cox proportional-hazard model. CI denotes confidence interval.
Symbols of p-values for trend test: ***: p,0.0001; **: p,0.01
The Paris Prospective Study I.
doi:10.1371/journal.pone.0021310.t002
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current physical activity and blood level of total cholesterol. As
shown in figure 1, the overall survival rate decreased significantly
by quartile of resting heart-rate. As shown in figures 2 and 3, the
pattern of the relationship between heart-rate increase during
exercise and mortality was similar for cardiovascular and cancer
mortality.
Sensitivity analyses
When additional adjustments were made for baseline haemo-
globin level or white blood cell count, the results were unchanged.
Additional analyses were carried out excluding causes of death
assessed from death certificates only and after exclusion of the 48
cancer deaths occurred in the first 5 years after baseline, and
similar results were obtained. Finally, exclusion of the 271 subjects
with an ischemic response to exercise or of the 117 who had an
impaired chronotropic response (i.e. those who did not achieve 80
percent of the predicted maximal heart-rate defined as 220 beats
per minute minus age), also gave similar results. Similar results
were observed in both groups when cancer deaths were split into
smoking-related (n=306) and other cancers (n=465).
Discussion
In this prospective study of over 6000 asymptomatic middle-
aged men selected from a general population and followed for
mortality over 25 years, we found a continuous, graded and highly
significant association between increased heart rate and increased
risk of death from cancer. Our data confirmed the previously
reported association between increased heart rate and cardiovas-
cular deaths [1–22]. The major unexpected finding, however, was
that the magnitude of the heart-rate related risks were similar
between cardiovascular deaths and deaths from cancers. These
significant associations remained important and comparable, after
adjustment for traditional cardiovascular risk factors.
These findings appear robust as they persisted after exclusion of
deaths that occurred during the initial 5 years of follow-up
(possibly related to the existence of a disease already present at
inclusion although not clinically detectable) or deaths after age 65
(when causes of deaths were obtained from death certificates
rather than specific contemporaneous family and medical
inquiries). Furthermore, these associations between cancer mor-
tality and heart-rate appear credible and consistent, as they were
observed for all four of the measured heart-rate parameters
(resting, exercise, recovery and change over 5 years).
Exercise tests are mainly indicated in the cardiovascular field to
detect subclinical ischemic heart disease and/or ventricular
arrhythmias. The heart-rate pattern during exercise and recovery
has been shown to be strongly predictive of cardiovascular and all-
cause mortality. [6–8,11,15,16]. By contrast, data concerning
heart-rate and cancer mortality risk are much more sparse. An
association between a high level of resting heart-rate and cancer
mortality was first hypothesized in 1981, when Persky et al.
published three observational studies together, concerning middle-
aged men from Chicago [24]. In this paper, a significant
association was noted in two but not in the third study, however
Figure 1. Multivariate adjusted overall survival rate by quartile of resting heart-rate. The Paris Prospective Study I.
doi:10.1371/journal.pone.0021310.g001
Heart Rate and Risk of Cancer Death in Healthy Men
PLoS ONE | www.plosone.org 4 August 2011 | Volume 6 | Issue 8 | e21310in one of the ‘‘positive’’ studies, the association was no longer
significant when deaths in the first two years of follow-up where
excluded (suggesting the possibility of subclinical cancer already
being present in some of the tachycardic subjects). Resting heart-
rate was the only heart-rate parameter measured.
In a more extensive follow-up of these Chicago studies
published in 1999 and involving men and women of different
ages, Greenland et al. found a weak but significant association
between heart-rate and subsequent cancer mortality in middle-
aged men and women (relative risk 1.20, CI: 1.11 to 1.28 in men
and 1.15, CI: 1.05 to 1.26 in women) but not in young or older age
groups [27]. Similarly, Thomas et al found a graded relationship
between heart-rate and cancer risk after 8 years follow-up in a
large group of middle-aged men, [23] however in both of these
studies only one heart-rate parameter (resting) was studied, on only
one single occasion. [23,27] More recently Kristal Boneh et al.
reported a lack of association between resting heart-rate and
cancer deaths, but young to middle-aged men were followed for
only 8 years and there were only 45 cancer deaths recorded [21].
Thus previously published work has been somewhat inconsistent
and inconclusive, regarding a possible relationship between heart-
rate and cancer.
With the exceptions of tobacco exposure for lung cancer and
familial history for colorectal malignancy, there have been few risk
factors associated with cancer death which confer as substantial a
relative risk, as did heart-rate in the present study [28–29].
The mechanisms that could explain the association between
heart-rate and cancer mortality are unclear. Is heart rate a marker
of risk for developing cancer, or a marker of risk of dying if one
individual develops cancer?
One possibility is that heart-rate increase might be a marker of
chronic stress and anxiety, which may in turn be related to an
increased risk for cancer. Recent data suggest that the link between
chronic stress and cancer might be related to genetic instability as
a consequence of telomere length reduction and telomerase
activity decrease [30].
Another possibility is that low-grade inflammation which is
present in certain malignant conditions may play a role although it
is not known to what extent such inflammation might be
associated with heart-rate increase. C-reactive protein measure-
ments were not available at baseline (1967–72) in the present
study, however when additional adjustments were made for white
blood cell count (reflecting to some extent the inflammatory
process), our results were unchanged. Similarly, subclinical
anaemia is an unlikely explanation, as adjusting for baseline
haemoglobin did not alter the strengths of associations observed.
It is tempting to speculate a potential role for autonomic
imbalance. Heart-rate is a general integrator of many physiologic
systems such as cardiovascular, respiratory and neuropsychologic.
An increase in heart-rate is generally interpreted as mediated by
an imbalance between vagal and adrenergic tone [31], which may
in turn be related to cancer risk. We could envisage the autonomic
Figure 2. Multivariate adjusted cardiovascular survival rate by quartile of heart-rate increase during exercise. The Paris Prospective
Study I.
doi:10.1371/journal.pone.0021310.g002
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cells in a given tissue. We could also envisage that subjects with
pre-existing disturbance of their autonomic system may have a
lower immunity defense system and an increased risk of dying if
the individual develops cancer. Further works are clearly needed
to address these important issues.
In any event, it seems likely that heart-rate is an epiphenom-
enon whereby an underlying factor separately causes heart-rate
increase and cancer risk, although a direct link cannot be
confidently excluded.
The present results emphasise the potential prognostic value of
heart-rate and suggest a need to standardize its recording. Heart-
rate measurement is inexpensive and non-invasive. If confirmation
of these results is provided from other studies, routine heart-rate
measurements at rest and on exercise may be worth considering in
cancer risk prediction algorithms. Our results however, do not
suggest a ‘‘threshold’’ level of risk above a certain specific heart-
rate, rather a continuous and progressive relationship with cancer
risk.
There are limitations of this study. Certain important cancer
risk factors were not recorded, such as family history of colorectal
cancer or exposure to environmental tobacco smoke in non-
smokers. These were not clearly appreciated as risk factors at the
time of the baseline heart-rate examinations (1967–72). These
factors would seem unlikely, however, to have explained the
significant heart-rate relationships observed. Furthermore, only
men were studied and thus the results cannot be considered
applicable to women. Self-report was relied upon for tobacco and
alcohol consumption. Deaths over age 65 years were categorized
by death certificates only, with causes of death not confirmed by
specific additional enquiries. However, a systematic confounding
of our results appears unlikely, especially as the associations were
of similar magnitude when certificated deaths (over age 65 years)
were excluded from the analyses.
As a long-term cohort study, there have been changes in
exposure since baseline assessment that could be related to cancer
incidence and mortality. In addition, there have been secular
changes in cancer screening strategies (including colorectal and
prostate cancer) and treatment since the study’s inception.
Moreover, we studied only cancer mortality and not non-fatal
cancer rates. Taken altogether, these issues should be carefully
considered in the interpretation of our results.
Our population consisted of asymptomatic healthy males
employed by the Paris Civil Service. Socioeconomic status,
prevalence of smoking, extent of alcohol use, and other factors
might differ from the general population. Therefore, the extent to
which the present findings can be generalized to a more unselected
or recent population is unclear. The present results were observed
after statistical adjustment for level of physical activity at inclusion.
We have no data related to physical activity prior to enrollment or
as a child or youth.
In summary, we have found a significant, strong and graded
relationship between increased resting heart-rate, heart rate
changes during exercise and over time and cancer mortality in a
Figure 3. Multivariate adjusted cancer free survival rate by quartile of heart-rate increase during exercise. The Paris Prospective Study I.
doi:10.1371/journal.pone.0021310.g003
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confirmatory studies are required and the mechanisms for such an
association are unknown, heart-rate parameters may prove to be a
simple and non-invasive stratification tool for the subsequent risk
of malignant disease.
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